The shortage of injectable opioids is reaching critical levels in hospitals nationwide and leaving health system pharmacists scrambling to find alternative treatment options for patients.
A recall is active for more than 75 lots of two separate drugs over sterility concerns.
Research found that the implementation of a structured research training program for pharmacists resulted in an increase in pharmacist-led research and publication.
Plastic containers filled with an IV medication are being recalled due to leaking potential.
The FDA is recalling a skeletal muscle relaxant used as part of general anesthesia.